Navigation Links
Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results and Corporate Update on March 12, 2009
Date:3/5/2009

SAN DIEGO, March 5 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today announced that it will release its fourth quarter and full year ended December 31, 2008 financial results after the market closes on Thursday, March 12, 2009.

Cadence management will host a conference call and live webcast to discuss the financial results and provide a clinical program update on Thursday, March 12, 2009 at 1:30 pm Pacific Time (4:30 pm Eastern Time). Interested investors may participate in the conference call by dialing 877-681-3371 (domestic) or 719-325-4846 (international). To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page. A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, Acetavance(TM) (intravenous acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit www.cadencepharm.com.

Cadence(TM), Acetavance(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals,
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
2. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIO Investor Forum
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
8. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
9. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
11. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Graphite Metallizing Corporation announces ... mounted in stainless steel pillow blocks. This series ... with the application and installation versatility of pillow ... work exceptionally well when submerged in water, ... such as acids, alkalies, hydrocarbons, black liquor, and ...
(Date:5/23/2013)... 23, 2013 PuraMed BioScience ® , ... of over-the-counter (OTC) medicinal and healthcare products, announced ... the company based on low market capitalization valuation. ... All Natural Product to Treat Migraine Headaches ... Prescription Competitor , Currently Available Nationwide at ...
(Date:5/23/2013)... The maker community is a contemporary group ... focus on learning practical skills while applying them creatively ... their ideas to life via crowdfunding. A subgroup within ... projects using biology. Glowing Plant has worked for months ... glow with bioluminescence genes, and has now pursued crowdfunding ...
(Date:5/23/2013)... MARINO, Calif. , May 23, 2013 /PRNewswire/ ... today a strategic alliance with DAK Renewable Research ... the corn oil yield. VG Energy is a ... (OTC Pink: VGLS). VG Energy,s exclusively ... to increase the oil yield in plants, possessing ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3
... in Detecting ... Validated Trofile, SOUTH SAN FRANCISCO, Calif., Dec. 19 ... that Pfizer Inc (NYSE:,PFE), the manufacturer of Selzentry(TM) (maraviroc), ... Trofile Assay and Pathway,Diagnostics, SensiTrop Assay. Pfizer concluded, based ...
... 19 Interleukin Genetics,Inc. (Amex: ILI ) ... Innovations Inc., has converted a total of $2,039,680 ... The converted debt represents,principal and accrued interest from ... which were to mature on December 31, 2007. ...
... A free white paper to help,biotechnology ... minimize the risk of infection in the ... ., Exposure to infectious biological agents ... many routine cell and tissue culture,techniques used ...
Cached Biology Technology:Study Reaffirms Superiority of Trofile(TM) Assay 2Study Reaffirms Superiority of Trofile(TM) Assay 3Study Reaffirms Superiority of Trofile(TM) Assay 4Study Reaffirms Superiority of Trofile(TM) Assay 5Study Reaffirms Superiority of Trofile(TM) Assay 6Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock 2Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock 3Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control 2
(Date:5/24/2013)... Studying complex systems like ecosystems can get messy, ... other big unknowns like climate change. , In ... the Proceedings of the National Academy of Sciences ... validate a fundamental assumption at the very heart of ... , To model how climate changes may impact biodiversity, ...
(Date:5/24/2013)... A frequently expressed concern in the ongoing public health ... especially those that are nutrient dense. A new ... Provide Most Nutrients Per Penny," published in the journal ... of the best nutritional values in the produce aisle, ... than most other raw vegetables and delivering one of ...
(Date:5/24/2013)... largest and fastest growing open-access publishers, today announces the ... . , A broad scope journal covering all specialties, ... and interactive web platform for the research community to ... Frontiers, real-time and interactive peer-review enables fast, fair and ... an average of three months from submission to final ...
Breaking Biology News(10 mins):Understanding the past and predicting the future by looking across space and time 2New research shows that potatoes provide one of the best nutritional values per penny 2Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3
... the silk moth,s antenna, University of Michigan researchers led ... that could advance understanding of a class of neurodegenerative ... work is newly published online in Nature Nanotechnology ... associate professor in the U-M departments of Biomedical Engineering ...
... R.I. [Brown University] Excessive weight gain isn,t healthy ... can do lasting harm to the mother and baby ... Hospital are encouraged by a new study describing an ... "This study suggests that a lifestyle intervention can help ...
... and scholar Issac Asimov once said, "The most exciting phrase ... is not ,Eureka!, but ,That,s funny., " This recently ... observed something they did not expect. In a ... Berlin-based team reports that it has uncovered surprising new details ...
Cached Biology News:Silk moth's antenna inspires new nanotech tool with applications in Alzheimer's research 2Intervention helps women manage weight during and after pregnancy 2Intervention helps women manage weight during and after pregnancy 3Intervention helps women manage weight during and after pregnancy 4Researchers develop curious snapshot of powerful retinal pigment and its partners 2Researchers develop curious snapshot of powerful retinal pigment and its partners 3
...
p27 rabbit polyclonal antibody...
... Rabbit polyclonal to Ki67 - Proliferation ... prototypic cell cycle related nuclear protein, expressed ... the active cell cycle (G1, S, G2 ... resting (G0) cells. Ki67 antibodies are useful ...
UBC13 Antibody...
Biology Products: